Ebola study in macaques provides timeframes for post-mortem viral stability

February 12, 2015, NIH/National Institute of Allergy and Infectious Diseases
The Ebola virus, isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells in a BSL-4 suite at Rocky Mountain Laboratories. Credit: NIAID

To determine how long Ebola virus could remain infectious in a body after death, National Institutes of Health (NIH) scientists sampled deceased Ebola-infected monkeys and discovered the virus remained viable for at least seven days. They also detected non-infectious viral RNA for up to 70 days post-mortem.

The study, published in Emerging Infectious Diseases, suggests that Ebola transmission from deceased individuals may be possible for an extended period of time following death, underscoring the importance of using safe practices for handling corpses. The research also highlights oral swabbing of bodies as a reliable and safer alternative to riskier procedures for obtaining diagnostic samples.

To conduct this study, scientists at NIH's National Institute of Allergy and Infectious Diseases tested samples from five deceased macaques used in Ebola virus studies and euthanized after showing signs of disease. To assess the stability of the virus post-mortem, the scientists placed the bodies in a chamber to mimic environmental conditions in West Africa. After the scientists sampled seven different body surfaces and removed tissue from four internal organs, they measured the amount of live Ebola virus and viral RNA, and compared test results at various times. The group determined that live virus was detectable in surface swabs up to seven days after death, and in the tissue samples up to three days post-mortem. Viral RNA was detectable in several swab and tissue types for up to 10 weeks.

The scientists believe these findings are likely to be consistent for non-human primates such as gorillas and monkeys. In fact, they designed the study to test animals found dead in the wild, but shifted the timing and emphasis to human implications related to the ongoing West Africa Ebola outbreak.

Explore further: Drug targeting Ebola virus protein VP24 shows promise in monkeys

More information: J Prescott et al. Post-mortem stability of Ebola virus. Emerging Infectious Diseases DOI: 10.3201/eid2105.150041 (2015).

Related Stories

Drug targeting Ebola virus protein VP24 shows promise in monkeys

February 10, 2015
An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration ...

Risks for Ebola virus-infected pregnant women discussed

January 22, 2015
(HealthDay)—Ebola virus-infected pregnant women are at risk for adverse maternal and fetal outcomes, according to an article published online Jan. 14 in BJOG: An International Journal of Obstetrics & Gynaecology.

Study shows how Ebola becomes lethal as it spreads

January 21, 2015
Scientists investigated why Ebola virus is so deadly when it spreads from animals to humans and then from human-to-human contact. The research team looked at the Zaire Ebola strain in an animal system to understand how it ...

Sperm can carry Ebola for 82 days: WHO

November 28, 2014
Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

Ebola: Simple methods of protection

October 7, 2014
Preventing infection by the Ebola virus entails simple but rigorously-observed methods of barrier protection and monitoring for signs of ill-health, say experts.

Scientists find Ebola virus is mutating

January 30, 2015
(Medical Xpress)—Researchers working at Institut Pasteur in France have found that the Ebola virus is mutating "a lot" causing concern in the African countries where the virus has killed over eight thousand people in just ...

Recommended for you

Home-based biofeedback therapy is effective option for tough-to-treat constipation

October 22, 2018
Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.